News Quantified

BEAT – heartbeam, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference

Credit-Card Sized Device Wins FDA Clearance for At-Home Heart Monitoring [Globe and Mail, The (Toronto, Canada)]

Top Midday Gainers [Yahoo! Finance]

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

-3.4%

BEAT

Speculative Buy

Speculative Buy

SPECULATIVE BUY

Form 4 HeartBeam, Inc. For: Dec 17 Filed by: STROME MARK E

Form 4 HeartBeam, Inc. For: Dec 17 Filed by: de Urioste George

Form 8-K HeartBeam, Inc. For: Nov 20

Top News Gainers

3/24 Form DEFA14A BIOTELEMETRY, INC. 10.2%

11/6 BioTelemetry Inc (NASDAQ: BEAT) had its "buy" rating re-affirmed by analysts at Lake Street Capital. They now have a $80.00 price target on the stock, down previously from $90.00. 8.8%

3/19 BioTelemetry Inc (NASDAQ: BEAT) had its price target lowered by analysts at Benchmark Co. from $82.00 to $55.00. They now have a "buy" rating on the stock. 6.9%

4/22 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $47.00 price target on the stock. 6.3%

1/6 Form 4 BIOTELEMETRY, INC. For: Dec 31 Filed by: Ferola Peter 5.4%

4/27 BioTelemetry, Inc. to Move to Virtual-only Annual Stockholder Meeting for 2020 5.0%

7/30 Q2/2019 6/30/2019 EPS 0.530 ZacksConsensus 0.450 ActVsEst 0.080 - Beat 4.9%

11/4 BioTelemetry Q3 Earnings Preview [Seeking Alpha] 4.4%

4/8 Form 4 BIOTELEMETRY, INC. For: Apr 06 Filed by: Stoica Andrei G 3.6%

10/11 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%

Top News Decliners

2/26 Q4/2019 12/31/2019 EPS 0.480 ZacksConsensus 0.480 ActVsEst 0.000 - In-Line -6.2%

11/9 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%

8/1 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $53.00 price target on the stock. -5.5%

7/30 BioTelemetry Inc (BEAT) Q2 2019 Earnings Call Transcript [The Motley Fool] -5.4%

2/28 Form 10-K BIOTELEMETRY, INC. For: Dec 31 -5.1%

2/20 Form 4 BIOTELEMETRY, INC. For: Feb 18 Filed by: Capper Joseph H -4.5%

6/26 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -4.1%

8/14 BioTelemetry: A Strong Buy At 52-Week Lows As A Key Part Of Apple's Heart Study Innovation [Seeking Alpha] -3.8%

4/27 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.1%

5/21 Form 4/A BIOTELEMETRY, INC. For: May 03 Filed by: GORMAN KIRK E -3.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day